How Hard Will Coronavirus Hit U.S., Global Economies?
COVID-19 poses serious risk of economic damage, possibly even a recession, even as its health impacts will be limited.
Markets are panicking about coronavirus. Should you? No. But the risks are serious. The virus itself is dangerous but not dire, based on the outbreaks that have happened so far. It’s highly infectious, but seems far less deadly than SARS, which killed about 10% of its victims. More people are likely to die of the seasonal flu this year than of coronavirus, based on recent trends.
The Federal Reserve is bound to cut interest rates. But that won’t do much. Availability of credit isn’t the problem. Any Fed cuts will be largely symbolic. Interest rates, short- and long-term, are likely to be depressed while the panic lasts. On employment, we see a modest effect: some layoffs, but the unemployment rate is unlikely to rise past 4% from its current 3.6%.
However bad the situation gets, the hit to global trade is already a given. Expect shortages of certain goods to begin by late March or April as inventories run out, especially so for electronics, ingredients for generic drugs and automotive parts.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
The U.S. imports more than half of computers and electronics for smart phones, tablets and many other devices from Asia. So while it’s too early to know which particular products might be hurt most, if you’re in the market for a gadget like a new phone or virtual-reality headset, you might want to buy now. Similarly, if you rely on a generic drug, consider reaching out to your doctor to check on name-brand alternatives or getting a prescription for a longer supply. Oh, and garlic. With China providing 70% of the U.S. consumption, you might want to set some aside to keep enough zest in your cooking. In the longer run, expect businesses to rethink their global supply chains and bring more production home. We are already hearing of such plans in the works.
As for the stock market: Count on more volatility, with further selloffs on any bad news, and brief rallies on any hopeful news. How much lower stocks go is impossible to say. We advise exercising caution about making any big moves, either buying or selling. Sometimes during turbulent times, it’s best to sit tight.
So, where does this all end? With the development of a better virus test kit, drugs that can treat the effects and lower the death rate, and with a vaccine. Better test kits have been developed, but await production and distribution. Several possible vaccines have been proposed, and will soon begin human testing. But it is likely to be nine to 12 months before any vaccine will become widely available.
David is both staff economist and reporter for The Kiplinger Letter, overseeing Kiplinger forecasts for the U.S. and world economies. Previously, he was senior principal economist in the Center for Forecasting and Modeling at IHS/GlobalInsight, and an economist in the Chief Economist's Office of the U.S. Department of Commerce. David has co-written weekly reports on economic conditions since 1992, and has forecasted GDP and its components since 1995, beating the Blue Chip Indicators forecasts two-thirds of the time. David is a Certified Business Economist as recognized by the National Association for Business Economics. He has two master's degrees and is ABD in economics from the University of North Carolina at Chapel Hill.
-
Strategies to Optimize Your Social Security Benefits
To maximize what you can collect, it’s crucial to know when you can file, how delaying filing affects your checks and the income limit if you’re still working.
By Jason “JB” Beckett Published
-
Don’t Forget to Update Beneficiaries After a Gray Divorce
Some states automatically revoke a former spouse as a beneficiary on some accounts. Waivers can be used, too. Best not to leave it up to your state, though.
By Andrew Hatherley, CDFA®, CRPC® Published
-
The Robots Are Coming... But Not For a While
The Kiplinger Letter There’s excitement in the tech sector over the potential of humanoid robots, but widespread adoption is likely to be years away.
By John Miley Published
-
Farmers Face Another Tough Year As Costs Continue to Climb: The Kiplinger Letter
The Kiplinger Letter Farm income is expected to decline for a second year, while costs continue to up-end farm profitability.
By Matthew Housiaux Published
-
H-1B Work Visa Rules Get a Revamp
The Kiplinger Letter H-1B visas allow employers to hire high-skilled foreign workers. Regulators have finalized new rules for this visa program following last fall's proposal.
By Matthew Housiaux Published
-
Woes Continue for Banking Sector: The Kiplinger Letter
The Kiplinger Letter Regional bank stocks were hammered recently after news of New York Community Bank’s big fourth-quarter loss.
By Rodrigo Sermeño Published
-
Are College Athletes Employees of Their Schools?: The Kiplinger Letter
The Kiplinger Letter A recent ruling has ramifications for labor relations and the unionization of student athletes.
By Sean Lengell Published
-
Salton Sea Clean Energy and Lithium Project Gets Approval: The Kiplinger Letter
The Kiplinger Letter California's Salton Sea is due to see the construction of a new lithium extraction and geothermal clean energy power plant.
By Matthew Housiaux Published
-
More Woes for Anheuser-Busch as a Strike Looms: The Kiplinger Letter
The Kiplinger Letter Drinkers of Anheuser-Busch beers may want to stock up soon. A looming strike threatens to shutter its U.S. breweries later this month.
By Sean Lengell Published
-
The Auto Industry Outlook for 2024
The Kiplinger Letter Here's what to expect in the auto industry this year. If you’re in the market for a car it won’t be quite as daunting as it was during the pandemic and after.
By David Payne Published